There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Aidan's Law

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Public Health Service Act, in relation to requiring adrenoleukodystrophy screening of newborns.


Actions Overview (1)

Date
03/03/2016 Introduced in House

All Actions (3)

Date
03/04/2016 Referred to the Subcommittee on Health.
Action By: House Energy and Commerce
03/03/2016 Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
03/03/2016 Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce03/03/2016 Referred to
House Energy and Commerce Subcommittee on Health03/04/2016 Referred to

Related Bills (1)

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (7)

  • Advisory bodies
  • Child health
  • Health promotion and preventive care
  • Hereditary and development disorders
  • Medical tests and diagnostic methods
  • Neurological disorders

Latest Summary (1)

There is one summary for H.R.4692. View summaries

Shown Here:
Introduced in House (03/03/2016)

Aidan's Law

This bill amends the Public Health Service Act to require hospitals, child care centers, clinics, and similar institutions caring for infants who are 28 days or less of age to administer to such infants a test for adrenoleukodystrophy, a progressive genetic disease that can cause behavioral changes, seizures, and other neurological symptoms.

To be eligible for funds under the Heritable Disorders Program, a state must establish adrenoleukodystrophy testing standards and procedures. These standards and procedures are subject to review and approval by the Advisory Committee on Heritable Disorders in Newborns and Children. The committee must establish standards and procedures for states without approved standards and procedures.